Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, and Safety of Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, in Japanese Patients With Type 2 Diabetes Mellitus

Published 2014 View Full Article

Authors

Keywords

Journal

CLINICAL THERAPEUTICS

Volume 36, Issue 11, Pages 1606-1615

Publisher

Elsevier BV

Online

2014-09-05

DOI

10.1016/j.clinthera.2014.08.001

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CLINICAL THERAPEUTICS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.